Results 161 to 170 of about 1,848 (184)

Macitentan/selexipag/sildenafil

Reactions Weekly, 2021
openaire   +1 more source

Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist

European Journal of Clinical Pharmacology, 2016
Jasper Dingemanse
exaly  

Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects

British Journal of Clinical Pharmacology, 2017
Jasper Dingemanse, Shirin Bruderer, Atef Halabi   +2 more
exaly  

Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies

Journal of Clinical Pharmacology, 2017
Raktim K Ghosh, Dhrubajyoti Bandyopadhyay, Samhati Mondal   +2 more
exaly  

Selexipag/treprostinil

Reactions Weekly, 2018
openaire   +1 more source

Nitric-oxide/selexipag

Reactions Weekly, 2021
openaire   +1 more source

Metamfetamine/selexipag/treprostinil

Reactions Weekly, 2020
openaire   +1 more source

Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment

British Journal of Clinical Pharmacology, 2016
Jasper Dingemanse, Andreas Krause, Atef Halabi   +2 more
exaly  

Ambrisentan/selexipag

Reactions Weekly, 2018
openaire   +1 more source

Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)

Journal of Heart and Lung Transplantation
Vallerie McLaughlin
exaly